Clinical Trial: AI-Driven Early Detection of Skin Cancer

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144306) titled 'AI-Driven Early Detection of Skin Cancer' on Aug. 20.

Brief Summary: This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.

Study Start Date: Oct. 01

Study Type: OBSERVATIONAL

Condition: Skin Cancer Melanoma

Intervention: DIAGNOSTIC_TEST: Smartphone-based AI skin lesion analysis (NuvanaDx platform).

Smartphone-based AI skin lesion analysis (NuvanaDx platform).

Recrui...